Epstein Secrets

eutical companies that ma=e nearly all the IV solutions used in the United States. It was a rare unguarded c=mment. Ms. Spak — like a spokesman for Hospira, another giant in the fie=d — later insisted that all information about saline solution prices was private. In fact, manufacturers ar= required to

ut there will be serious, serious difficulties with it=94 that could result in delays and errors initially, said Robert H. Bonthius Jr., a lawyer at the Legal Aid Society of Cleveland. "It's=an extremely ambitious program, well-intentioned, that is going to be very=difficult to accomplish, and it's going to be months and maybe ye

ceutical companies that make nearly all the IV solutions used in the United States. It was a rare unguarded comment. Ms. Spak — like a spokesman for Hospira, another giant in the field — later insisted that all information about saline solution prices was private. In fact, manufacturers are required to r

, but there will be serious, serious difficulties with it” that could result in delays and errors initially, said Robert H. Bonthius Jr., a lawyer at the Legal Aid Society of Cleveland. “It’s an extremely ambitious program, well-intentioned, that is going to be very difficult to accomplish, and it’s going to be months and maybe year

aceutical companies that make nearly all the IV solutions used in the United States. It was a rare unguarded comment. Ms. Spak — like a spokesman for Hospira, another giant in the field — later insisted that all information about saline solution prices was private. In fact, manufacturers are required to re

, but there will be serious, serious difficulties with it" that could result in delays and errors initially, said Robert H. Bonthius Jr., a lawyer at the Legal Aid Society of Cleveland. "It's an extremely ambitious program, well-intentioned, that is going to be very difficult to accomplish, and it's going to be months and maybe year